Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Velcade®-Melphalan Association as Conditioning Regimen Before Autologous Stem-cell Transplantation in Multiple Myeloma Patients Under 65 Years

NCT00642395 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00642395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00642395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Velcade®-Melphalan Association as Conditioning Regimen Before Autologous Stem-cell Transplantation in Multiple Myeloma Patients Under 65 Years
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2007
Completion date
July 31, 2011
Enrollment
61 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma